April 22, 2026 01:39 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘PM Modi is a terrorist’: Mallikarjun Kharge sparks row; BJP hits back | ‘What kind of order is this?’: Mamata slams ECI’s bike curbs in poll-bound Bengal, calls it ‘mischief’ | ‘90% of women can’t do politics without entering male politicians’ rooms’: Pappu Yadav sparks row; BJP targets Congress | Tim Cook to step down as Apple CEO; John Ternus named successor | 15 killed, 20 injured as bus plunges into gorge in J&K’s Udhampur | Oil jumps over 5% as Strait of Hormuz closure fuels supply fears | Pushback from smartphone makers: Centre drops Aadhaar app pre-install plan — report | Meta eyes first wave of layoffs on May 20: Report | TCS breaks silence on Nida Khan: ‘No HR role, no power’ in Nashik case | ‘Panic reaction’: Rahul Gandhi on women’s bill, says PM Modi ‘wants to send a message’
AstraZeneca
WIKIMEDIA COMMONS

WHO to hold meeting on AstraZeneca Vaccine safety on Tuesday

| @indiablooms | Mar 16, 2021, at 02:42 pm

Geneva/Sputnik: The World Health Organization's (WHO) global advisory committee on vaccine safety will hold a meeting on Tuesday on the safety of the AstraZeneca vaccine, WHO Director General Tedros Adhanom Ghebreyesus said.

"The WHO's advisory committee on vaccine safety has been reviewing the available data, is in close contact with the European Medicines Agency and will meet tomorrow," Tedros said at a briefing.

The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has scheduled an extraordinary meeting for March 18, during which it intends to evaluate all recent incidents related to vaccinations with AstraZeneca, the regulator said.

"EMA’s safety committee (PRAC) will further review the information tomorrow (Tuesday) and has called an extraordinary meeting on Thursday 18 March to conclude on the information gathered and any further actions that may need to be taken," the statement says.

EMA also confirmed that during the investigation, the regulator proceeds from the position that the benefits of the AstraZeneca vaccine outweigh the risks associated with it.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.